FTSE 250: Indivior dives, Marston's bubbles up

Along with its larger sister index, London's FTSE 250 index finished lower on Friday, led by a big fall for drug developer Indivior. Indivior tumbled 22% as its main revenue-generating product, Suboxone film, came under pressure overnight as rival Dr Reddy's Labs won regulatory approval to its generic version of the sublingual film. Assuming a 40% net price reduction in the second half of 2018 and with generic film taking an 11% share in the second half, Jefferies analysts estimated that EPS in ...

Den vollständigen Artikel lesen ...